Fundraise / allotmentFiled on BSE ·
Capital Infra Trust approves utilization of preferential issue proceeds and PMA amendment
Capital Infra Trust · Construction
What the filing says
- ₹124.999 crore from preferential issue proceeds to provide shareholder loans for repayment/prepayment of Target SPVs' debt
- No funds allocated for acquisition of Target SPVs/assets or general corporate purposes
- Clause 10.2 of Project Management Agreement amended to restrict Project Manager’s termination rights after 5 years with specified conditions
Original filing
Reg 23(5)(i): Disclosure of material issue
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Waaree Energies
Electrical Equipment
Revenue: Rank 1Margin: Rank 1
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
More from Capital Infra Trust
- Board / shareholder meeting outcomeCapital Infra Trust announces results of Postal Ballot on key resolutions dated Aug 17, 2026
Other fundraise / allotment filings this fortnight
- Fundraise / allotmentInox GreenInox Green Energy Services Ltd allotted 1.81 crore equity shares via QIP in Sept 2026
- Fundraise / allotmentInox GreenInox Green Energy Services completes Qualified Institutions Placement on Sept 29, 2026
- Fundraise / allotmentBharat Parenterals LtdBharat Parenterals Limited approves preferential allotment of 9.13 lakh equity shares
- Fundraise / allotmentAurum Proptech LtdAurum PropTech allots 1.98 crore equity shares to REA India on preferential basis
- Fundraise / allotmentAurum Proptech LtdAurum PropTech Limited allots 1.98 crore shares to REA India on preferential basis
- Fundraise / allotmentRepco Home FinRepco Home Finance approved raising ₹1500 Cr NCDs and ₹1000 Cr Commercial Paper
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.
